Project on TDCS Intervention to Enhance Advanced Social Cognitive Functions in Drug Rehabilitation Individuals
Launched by SHAANXI NORMAL UNIVERSITY · Mar 16, 2025
Trial Information
Current as of April 30, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age between 30 and 60 years;
- • fulfilling the diagnostic criteria for severe substance use disorder as specified in the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders.
- • a history of heroin use exceeding ten years, with a daily average intake of at least 0.1 grams.
- • abstinence duration of eight months or less, with a positive result of a urine test before entering the rehabilitation center.
- • no history of neuromodulation treatments such as tDCS within the past six months.
- Exclusion Criteria:
- • a history of alcohol dependence, neurological disorders, or other complex psychiatric conditions.
- • the presence of intracranial metallic implants or elevated intracranial pressure.
- • a history of epilepsy or recent electroencephalogram evidence of epileptiform activity.
- • the use of implanted electronic devices, such as pacemakers;.
- • scalp hyperalgesia or a tendency toward bleeding.
- • severe cardiac conditions.
About Shaanxi Normal University
Shaanxi Normal University is a distinguished academic institution located in Xi'an, China, renowned for its commitment to advancing education and research in various fields, including the health sciences. The university actively engages in clinical research initiatives aimed at addressing pressing healthcare challenges through innovative methodologies and interdisciplinary collaboration. By fostering partnerships with healthcare professionals and leveraging its robust academic resources, Shaanxi Normal University strives to contribute to the development of evidence-based medical practices and improve patient outcomes in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Xi'an, Shaanxi, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported